Updated efficacy and safety of tabelecleucel in patients with Epstein-Barr virus-positive (EBV(+)) leiomyosarcomas (LMS) Meeting Abstract


Authors: Jimenez-Kurlander, L. S.; Behr, G.; Bunin, N. J.; Doubrovina, E.; Dinavahi, R.; Gamelin, L.; Ghobadi, A.; Mascarenhas, L.; Nikiforow, S.; O'Reilly, R. J.; Price, A.; Shulkin, B.; Srinivasan, A.; Suser, S.; Wahlstrom, J.; Xing, B.; Prockop, S.
Abstract Title: Updated efficacy and safety of tabelecleucel in patients with Epstein-Barr virus-positive (EBV(+)) leiomyosarcomas (LMS)
Meeting Title: 64th Annual Meeting of the American Society of Hematology (ASH)
Journal Title: Blood
Volume: 140
Issue: Suppl. 1
Meeting Dates: 2022 Dec 10-13
Meeting Location: New Orleans, LA
ISSN: 0006-4971
Publisher: American Society of Hematology  
Date Published: 2022-11-15
Start Page: 7524
End Page: 7526
Language: English
ACCESSION: WOS:000893230300238
DOI: 10.1182/blood-2022-157765
PROVIDER: wos
Notes: Meeting Abstract -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Anita P Price
    53 Price
  2. Richard O'Reilly
    747 O'Reilly
  3. Stephanie Dana Suser
    19 Suser
  4. Gerald Gideon Behr
    29 Behr